| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acidosis | 5 | 2022 | 270 | 2.750 |
Why?
|
| Hyperammonemia | 5 | 2020 | 76 | 2.230 |
Why?
|
| Renal Dialysis | 26 | 2022 | 1783 | 2.090 |
Why?
|
| Acute Kidney Injury | 9 | 2022 | 1968 | 1.310 |
Why?
|
| Arteriovenous Shunt, Surgical | 5 | 2016 | 277 | 1.230 |
Why?
|
| Acid-Base Imbalance | 3 | 2021 | 41 | 1.210 |
Why?
|
| Acid-Base Equilibrium | 4 | 2022 | 185 | 1.140 |
Why?
|
| Forearm | 2 | 2016 | 409 | 0.890 |
Why?
|
| Antihypertensive Agents | 9 | 2016 | 2047 | 0.870 |
Why?
|
| Scurvy | 1 | 2022 | 29 | 0.840 |
Why?
|
| Kidney Failure, Chronic | 10 | 2017 | 2535 | 0.840 |
Why?
|
| Renal Replacement Therapy | 3 | 2019 | 257 | 0.800 |
Why?
|
| Amyloidosis | 7 | 2020 | 796 | 0.800 |
Why?
|
| Electrolytes | 2 | 2022 | 282 | 0.760 |
Why?
|
| Brachial Artery | 2 | 2016 | 369 | 0.710 |
Why?
|
| Alcohol Withdrawal Delirium | 1 | 2019 | 27 | 0.680 |
Why?
|
| 2-Propanol | 1 | 2019 | 28 | 0.680 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2020 | 187 | 0.670 |
Why?
|
| Carpal Tunnel Syndrome | 3 | 2020 | 300 | 0.650 |
Why?
|
| Uremia | 1 | 2018 | 200 | 0.610 |
Why?
|
| Pericarditis | 1 | 2018 | 128 | 0.600 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2016 | 549 | 0.590 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2017 | 95 | 0.590 |
Why?
|
| Hypertension, Renovascular | 3 | 2006 | 123 | 0.580 |
Why?
|
| Obesity, Morbid | 2 | 2020 | 1213 | 0.570 |
Why?
|
| Sodium | 1 | 2022 | 1622 | 0.570 |
Why?
|
| Renal Artery Obstruction | 4 | 2013 | 248 | 0.560 |
Why?
|
| Water-Electrolyte Balance | 1 | 2017 | 346 | 0.550 |
Why?
|
| Fructose | 1 | 2017 | 289 | 0.520 |
Why?
|
| Hepatic Encephalopathy | 1 | 2016 | 139 | 0.520 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2015 | 87 | 0.500 |
Why?
|
| Kidney Diseases | 7 | 2017 | 2148 | 0.500 |
Why?
|
| Liver Failure, Acute | 1 | 2016 | 165 | 0.500 |
Why?
|
| Hypertension | 10 | 2018 | 8479 | 0.490 |
Why?
|
| Tuberculosis, Lymph Node | 1 | 2014 | 19 | 0.480 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2014 | 76 | 0.470 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 961 | 0.470 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2014 | 66 | 0.460 |
Why?
|
| Carboplatin | 1 | 2017 | 801 | 0.460 |
Why?
|
| Magnesium | 1 | 2017 | 813 | 0.460 |
Why?
|
| Gastric Bypass | 2 | 2015 | 812 | 0.450 |
Why?
|
| Vascular Patency | 4 | 2015 | 887 | 0.430 |
Why?
|
| Anemia | 1 | 2022 | 1503 | 0.430 |
Why?
|
| Scleroderma, Systemic | 1 | 2016 | 323 | 0.410 |
Why?
|
| Kidney Transplantation | 5 | 2020 | 4251 | 0.390 |
Why?
|
| Veins | 1 | 2015 | 770 | 0.380 |
Why?
|
| Mucormycosis | 6 | 2020 | 97 | 0.380 |
Why?
|
| Hepatitis B | 1 | 2016 | 695 | 0.380 |
Why?
|
| Hospitalists | 1 | 2015 | 305 | 0.370 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 6 | 2016 | 1516 | 0.370 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 952 | 0.360 |
Why?
|
| Emergency Medical Services | 2 | 2016 | 1917 | 0.350 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 1410 | 0.340 |
Why?
|
| Organ Transplantation | 1 | 2019 | 1140 | 0.330 |
Why?
|
| Poisoning | 2 | 2020 | 249 | 0.320 |
Why?
|
| Alcoholism | 1 | 2019 | 1906 | 0.320 |
Why?
|
| Anemia, Hemolytic | 2 | 2023 | 168 | 0.320 |
Why?
|
| Contrast Media | 2 | 2021 | 5300 | 0.320 |
Why?
|
| Curriculum | 1 | 2021 | 3605 | 0.310 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2008 | 42 | 0.310 |
Why?
|
| Blood Pressure | 5 | 2016 | 8551 | 0.300 |
Why?
|
| Fibromuscular Dysplasia | 3 | 2006 | 58 | 0.300 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2008 | 84 | 0.290 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2006 | 65 | 0.280 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 1391 | 0.260 |
Why?
|
| Humans | 85 | 2023 | 744366 | 0.260 |
Why?
|
| Thrombosis | 3 | 2016 | 2968 | 0.240 |
Why?
|
| Kidney | 5 | 2020 | 7184 | 0.230 |
Why?
|
| Confusion | 2 | 2023 | 275 | 0.230 |
Why?
|
| Diagnosis, Differential | 11 | 2021 | 12961 | 0.230 |
Why?
|
| Fever | 2 | 2009 | 1616 | 0.220 |
Why?
|
| Osmolar Concentration | 3 | 2021 | 683 | 0.220 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 987 | 0.220 |
Why?
|
| Arm | 1 | 2015 | 589 | 0.210 |
Why?
|
| Vasodilation | 1 | 2016 | 944 | 0.210 |
Why?
|
| Acidosis, Lactic | 2 | 2021 | 142 | 0.210 |
Why?
|
| Renin-Angiotensin System | 4 | 2009 | 758 | 0.210 |
Why?
|
| Acetaminophen | 1 | 2006 | 545 | 0.210 |
Why?
|
| Syndrome | 3 | 2018 | 3252 | 0.210 |
Why?
|
| Middle Aged | 40 | 2023 | 213390 | 0.200 |
Why?
|
| Renal Artery | 2 | 2013 | 399 | 0.200 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2023 | 142 | 0.200 |
Why?
|
| Chloramines | 1 | 2000 | 14 | 0.190 |
Why?
|
| Kidney Function Tests | 2 | 2022 | 683 | 0.190 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2016 | 205 | 0.190 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 451 | 0.190 |
Why?
|
| Glomerulonephritis, Membranous | 2 | 2018 | 86 | 0.190 |
Why?
|
| Methemoglobinemia | 1 | 2000 | 44 | 0.190 |
Why?
|
| Deferoxamine | 4 | 1991 | 151 | 0.180 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2020 | 110 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 7282 | 0.180 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2014 | 1856 | 0.180 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2004 | 923 | 0.180 |
Why?
|
| Diazepam | 1 | 2020 | 205 | 0.180 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 5135 | 0.180 |
Why?
|
| Male | 40 | 2022 | 350115 | 0.180 |
Why?
|
| Acetone | 1 | 2019 | 43 | 0.170 |
Why?
|
| Female | 43 | 2023 | 380193 | 0.170 |
Why?
|
| Brain Abscess | 1 | 2020 | 118 | 0.170 |
Why?
|
| Ultrasonography | 6 | 2020 | 5984 | 0.170 |
Why?
|
| Adult | 29 | 2021 | 214052 | 0.170 |
Why?
|
| Kidney Glomerulus | 2 | 2018 | 697 | 0.170 |
Why?
|
| Heart Block | 1 | 2020 | 410 | 0.170 |
Why?
|
| Radiography, Abdominal | 2 | 2019 | 537 | 0.160 |
Why?
|
| Fatal Outcome | 3 | 2016 | 1851 | 0.160 |
Why?
|
| Ascorbic Acid | 1 | 2022 | 651 | 0.160 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2018 | 42 | 0.160 |
Why?
|
| Phenobarbital | 1 | 2019 | 193 | 0.160 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2018 | 33 | 0.160 |
Why?
|
| Postoperative Complications | 2 | 2019 | 15297 | 0.160 |
Why?
|
| Renal Veins | 1 | 2018 | 108 | 0.160 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2021 | 245 | 0.160 |
Why?
|
| Vascular Surgical Procedures | 2 | 2016 | 1476 | 0.160 |
Why?
|
| Hematuria | 2 | 2018 | 235 | 0.150 |
Why?
|
| Fluid Therapy | 1 | 2021 | 593 | 0.150 |
Why?
|
| Skin Diseases | 2 | 2016 | 1066 | 0.150 |
Why?
|
| Hematoma | 1 | 2022 | 758 | 0.150 |
Why?
|
| Decerebrate State | 1 | 2016 | 43 | 0.140 |
Why?
|
| Sodium Chloride | 2 | 2016 | 625 | 0.140 |
Why?
|
| Angioplasty, Balloon | 3 | 2013 | 653 | 0.140 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 412 | 0.140 |
Why?
|
| Tachycardia | 1 | 2019 | 619 | 0.140 |
Why?
|
| Cushing Syndrome | 1 | 2018 | 249 | 0.140 |
Why?
|
| Metformin | 2 | 2021 | 836 | 0.140 |
Why?
|
| Heparin Antagonists | 1 | 2016 | 32 | 0.140 |
Why?
|
| Thiosulfates | 1 | 2016 | 52 | 0.140 |
Why?
|
| Long QT Syndrome | 1 | 2020 | 453 | 0.140 |
Why?
|
| Facial Paralysis | 1 | 2020 | 338 | 0.130 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2016 | 138 | 0.130 |
Why?
|
| Beer | 1 | 1996 | 127 | 0.130 |
Why?
|
| Dipyridamole | 3 | 2012 | 145 | 0.130 |
Why?
|
| Thymus Neoplasms | 1 | 2018 | 268 | 0.130 |
Why?
|
| Physical Examination | 2 | 2016 | 1237 | 0.130 |
Why?
|
| Leiomyomatosis | 1 | 2016 | 70 | 0.130 |
Why?
|
| Protamines | 1 | 2016 | 106 | 0.130 |
Why?
|
| Anuria | 1 | 2015 | 15 | 0.130 |
Why?
|
| Azotemia | 1 | 2015 | 8 | 0.130 |
Why?
|
| Aged | 24 | 2023 | 163288 | 0.130 |
Why?
|
| Ammonia | 1 | 2016 | 239 | 0.130 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 525 | 0.130 |
Why?
|
| Radiography | 4 | 2016 | 7023 | 0.130 |
Why?
|
| Opportunistic Infections | 2 | 1988 | 389 | 0.130 |
Why?
|
| Liver Function Tests | 1 | 2016 | 528 | 0.130 |
Why?
|
| Gallbladder | 1 | 2016 | 302 | 0.120 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2016 | 152 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 1131 | 0.120 |
Why?
|
| Chelating Agents | 1 | 2016 | 380 | 0.120 |
Why?
|
| Duffy Blood-Group System | 1 | 2014 | 58 | 0.120 |
Why?
|
| Calciphylaxis | 1 | 2016 | 124 | 0.120 |
Why?
|
| Unconsciousness | 1 | 2016 | 263 | 0.120 |
Why?
|
| Enteral Nutrition | 1 | 2020 | 767 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 3 | 2015 | 2166 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2020 | 804 | 0.120 |
Why?
|
| Syncope | 1 | 2017 | 429 | 0.120 |
Why?
|
| Radioisotope Renography | 2 | 2006 | 62 | 0.120 |
Why?
|
| Blood Group Incompatibility | 1 | 2014 | 146 | 0.110 |
Why?
|
| Vitamins | 1 | 2022 | 1623 | 0.110 |
Why?
|
| Brain | 2 | 2020 | 26388 | 0.110 |
Why?
|
| Prisoners | 1 | 2016 | 297 | 0.110 |
Why?
|
| Femoral Fractures | 1 | 2017 | 376 | 0.110 |
Why?
|
| Drug Eruptions | 1 | 2016 | 297 | 0.110 |
Why?
|
| Creatine | 1 | 2015 | 421 | 0.110 |
Why?
|
| Hyponatremia | 1 | 1996 | 298 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2020 | 1162 | 0.110 |
Why?
|
| Ethanol | 1 | 2019 | 1342 | 0.110 |
Why?
|
| Diarrhea | 2 | 2021 | 1348 | 0.110 |
Why?
|
| Risk Factors | 11 | 2016 | 72296 | 0.110 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 594 | 0.100 |
Why?
|
| Stents | 1 | 2013 | 3282 | 0.100 |
Why?
|
| Vomiting | 1 | 2015 | 637 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 6539 | 0.100 |
Why?
|
| Factor V | 1 | 2012 | 178 | 0.100 |
Why?
|
| Hypoglycemic Agents | 2 | 2021 | 2873 | 0.100 |
Why?
|
| Medical History Taking | 1 | 2015 | 784 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2016 | 587 | 0.100 |
Why?
|
| Acute Disease | 2 | 2018 | 7147 | 0.090 |
Why?
|
| Vascular Grafting | 1 | 2012 | 143 | 0.090 |
Why?
|
| Aspirin | 3 | 2012 | 3283 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 1206 | 0.090 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 57776 | 0.090 |
Why?
|
| Erythrocyte Transfusion | 1 | 2014 | 565 | 0.090 |
Why?
|
| Migraine Disorders | 2 | 2017 | 1620 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2012 | 3070 | 0.080 |
Why?
|
| Adenovirus Infections, Human | 1 | 2009 | 71 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2006 | 1443 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2016 | 861 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3508 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 1239 | 0.080 |
Why?
|
| Chronic Disease | 5 | 2017 | 9145 | 0.080 |
Why?
|
| Cytosine | 1 | 2009 | 216 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2020 | 20130 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2013 | 1125 | 0.080 |
Why?
|
| Prognosis | 5 | 2016 | 29060 | 0.070 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2017 | 1209 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2016 | 2200 | 0.070 |
Why?
|
| Hypertension, Malignant | 1 | 2006 | 19 | 0.070 |
Why?
|
| Auscultation | 1 | 2006 | 42 | 0.070 |
Why?
|
| Nephrotic Syndrome | 2 | 2018 | 389 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 1513 | 0.070 |
Why?
|
| Survivors | 1 | 2017 | 2291 | 0.070 |
Why?
|
| Plethysmography | 1 | 2016 | 180 | 0.070 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 692 | 0.070 |
Why?
|
| Bone Cysts | 1 | 1986 | 47 | 0.070 |
Why?
|
| Captopril | 1 | 2006 | 272 | 0.070 |
Why?
|
| Drug Resistance | 2 | 2014 | 1608 | 0.070 |
Why?
|
| Time Factors | 4 | 2016 | 40075 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 2375 | 0.060 |
Why?
|
| Nitroglycerin | 1 | 2016 | 325 | 0.060 |
Why?
|
| Legionnaires' Disease | 1 | 1985 | 48 | 0.060 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2006 | 341 | 0.060 |
Why?
|
| United States | 8 | 2016 | 69872 | 0.060 |
Why?
|
| Proportional Hazards Models | 3 | 2015 | 12356 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2009 | 652 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 2865 | 0.060 |
Why?
|
| Angiotensin II | 2 | 2006 | 881 | 0.060 |
Why?
|
| Sex Factors | 2 | 2016 | 10400 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2006 | 280 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2282 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2017 | 2494 | 0.060 |
Why?
|
| Treatment Outcome | 8 | 2016 | 63107 | 0.060 |
Why?
|
| Celiac Artery | 1 | 2004 | 69 | 0.060 |
Why?
|
| Renin | 1 | 2006 | 642 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 458 | 0.060 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2004 | 97 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 1240 | 0.060 |
Why?
|
| Prospective Studies | 6 | 2016 | 53290 | 0.060 |
Why?
|
| Amlodipine | 1 | 2013 | 83 | 0.060 |
Why?
|
| Angiography | 2 | 2006 | 1639 | 0.060 |
Why?
|
| Treatment Failure | 2 | 2013 | 2618 | 0.060 |
Why?
|
| Drug Combinations | 2 | 2013 | 1958 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2016 | 9849 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 1996 | 3966 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 2736 | 0.050 |
Why?
|
| Graft Rejection | 2 | 2015 | 4397 | 0.050 |
Why?
|
| Kidney Tubular Necrosis, Acute | 2 | 1997 | 66 | 0.050 |
Why?
|
| Lung | 3 | 2018 | 9857 | 0.050 |
Why?
|
| Spinal Diseases | 1 | 1987 | 538 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 976 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3531 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 1423 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 3841 | 0.050 |
Why?
|
| Heptanoic Acids | 1 | 2013 | 343 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12244 | 0.050 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2002 | 103 | 0.050 |
Why?
|
| Lithium | 1 | 1984 | 601 | 0.050 |
Why?
|
| Comorbidity | 1 | 2016 | 10388 | 0.050 |
Why?
|
| Hemodialysis Solutions | 1 | 2000 | 8 | 0.050 |
Why?
|
| Hemolysis | 1 | 2023 | 420 | 0.050 |
Why?
|
| Logistic Models | 1 | 2016 | 13409 | 0.050 |
Why?
|
| Prevalence | 2 | 2016 | 15221 | 0.050 |
Why?
|
| Arthritis | 1 | 1986 | 661 | 0.050 |
Why?
|
| Dysarthria | 1 | 2020 | 57 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15078 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2015 | 77460 | 0.040 |
Why?
|
| Heroin Dependence | 1 | 2020 | 175 | 0.040 |
Why?
|
| Quality of Life | 1 | 2020 | 12802 | 0.040 |
Why?
|
| Peritoneal Dialysis | 1 | 2020 | 147 | 0.040 |
Why?
|
| Analgesics | 1 | 2006 | 1040 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 9955 | 0.040 |
Why?
|
| Nausea | 1 | 2021 | 674 | 0.040 |
Why?
|
| Creatinine | 2 | 2021 | 1919 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21748 | 0.040 |
Why?
|
| Glomerulonephritis | 1 | 2020 | 372 | 0.040 |
Why?
|
| Brucellosis | 1 | 1997 | 20 | 0.040 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2001 | 357 | 0.040 |
Why?
|
| Ischemia | 1 | 2006 | 1907 | 0.040 |
Why?
|
| Graves Disease | 1 | 1999 | 242 | 0.040 |
Why?
|
| Pyrroles | 1 | 2013 | 1146 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2009 | 2987 | 0.040 |
Why?
|
| Biopsy | 2 | 2018 | 6755 | 0.040 |
Why?
|
| Pancytopenia | 1 | 1997 | 104 | 0.040 |
Why?
|
| Nail-Patella Syndrome | 1 | 2016 | 13 | 0.040 |
Why?
|
| Heart Failure | 2 | 2021 | 10895 | 0.040 |
Why?
|
| Risk Assessment | 5 | 2015 | 23336 | 0.040 |
Why?
|
| Ramipril | 1 | 1996 | 95 | 0.030 |
Why?
|
| Diphosphonates | 1 | 2001 | 623 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 5692 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2018 | 648 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2013 | 979 | 0.030 |
Why?
|
| Abdominal Pain | 2 | 2018 | 1064 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 369 | 0.030 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2016 | 43 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 10637 | 0.030 |
Why?
|
| Diverticulitis | 1 | 2018 | 171 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 5953 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1997 | 393 | 0.030 |
Why?
|
| Birt-Hogg-Dube Syndrome | 1 | 2016 | 39 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 2018 | 546 | 0.030 |
Why?
|
| Drug Therapy, Combination | 3 | 2011 | 6489 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 15535 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2015 | 4196 | 0.030 |
Why?
|
| Fabry Disease | 1 | 2016 | 90 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2018 | 620 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1999 | 1032 | 0.030 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2016 | 111 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 56429 | 0.030 |
Why?
|
| Turner Syndrome | 1 | 2016 | 130 | 0.030 |
Why?
|
| Disease Progression | 3 | 2005 | 13286 | 0.030 |
Why?
|
| Podocytes | 1 | 2018 | 396 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 14723 | 0.030 |
Why?
|
| Edema | 1 | 2018 | 789 | 0.030 |
Why?
|
| Diuretics | 1 | 1997 | 591 | 0.030 |
Why?
|
| Cholecystitis | 1 | 2014 | 182 | 0.030 |
Why?
|
| Longevity | 1 | 2001 | 1071 | 0.030 |
Why?
|
| Premedication | 1 | 2014 | 258 | 0.030 |
Why?
|
| Proteinuria | 1 | 1996 | 658 | 0.030 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2016 | 241 | 0.030 |
Why?
|
| Hematocrit | 1 | 2014 | 636 | 0.030 |
Why?
|
| Leg | 1 | 2018 | 1116 | 0.030 |
Why?
|
| Graft Survival | 2 | 2015 | 3737 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2013 | 39052 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15520 | 0.030 |
Why?
|
| Dermatologic Agents | 1 | 2016 | 278 | 0.030 |
Why?
|
| Sodium, Dietary | 1 | 1996 | 418 | 0.030 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2014 | 367 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 8642 | 0.020 |
Why?
|
| Double-Blind Method | 4 | 2012 | 12025 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 633 | 0.020 |
Why?
|
| Fatigue | 1 | 2018 | 1531 | 0.020 |
Why?
|
| Amyloid | 2 | 1986 | 795 | 0.020 |
Why?
|
| Neurofibromatosis 1 | 1 | 2016 | 570 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2014 | 679 | 0.020 |
Why?
|
| Albuminuria | 2 | 2009 | 681 | 0.020 |
Why?
|
| Cardiovascular Diseases | 3 | 2013 | 15160 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2014 | 726 | 0.020 |
Why?
|
| Bence Jones Protein | 1 | 2009 | 18 | 0.020 |
Why?
|
| Immunoelectrophoresis | 1 | 2009 | 110 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1525 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2018 | 2036 | 0.020 |
Why?
|
| Adolescent | 4 | 2015 | 85779 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 10943 | 0.020 |
Why?
|
| Rhizopus | 1 | 1987 | 21 | 0.020 |
Why?
|
| Incidence | 3 | 2015 | 20952 | 0.020 |
Why?
|
| Tuberous Sclerosis | 1 | 2016 | 1029 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2012 | 674 | 0.020 |
Why?
|
| Ciprofloxacin | 1 | 1989 | 315 | 0.020 |
Why?
|
| Hemosiderosis | 1 | 1987 | 71 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2020 | 6442 | 0.020 |
Why?
|
| Aluminum | 1 | 1987 | 152 | 0.020 |
Why?
|
| Anticoagulants | 2 | 2018 | 4600 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2016 | 1563 | 0.020 |
Why?
|
| Dialysis | 1 | 2006 | 75 | 0.020 |
Why?
|
| Dyspnea | 1 | 2014 | 1303 | 0.020 |
Why?
|
| Hepatitis C, Chronic | 1 | 2014 | 1031 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2016 | 40559 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2013 | 1002 | 0.020 |
Why?
|
| Tenosynovitis | 1 | 1986 | 57 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 1739 | 0.020 |
Why?
|
| Carpal Bones | 1 | 1986 | 77 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2009 | 968 | 0.020 |
Why?
|
| Obesity | 1 | 2008 | 12746 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 25039 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2009 | 1101 | 0.020 |
Why?
|
| Legionella | 1 | 1985 | 30 | 0.020 |
Why?
|
| beta 2-Microglobulin | 1 | 1985 | 315 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5096 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2009 | 847 | 0.010 |
Why?
|
| Encephalitis | 1 | 1987 | 425 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2004 | 187 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 4153 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 2001 | 2646 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1985 | 337 | 0.010 |
Why?
|
| Laparotomy | 1 | 2004 | 473 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 6486 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 7658 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 7730 | 0.010 |
Why?
|
| Europe | 1 | 1987 | 3338 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 2002 | 440 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3047 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 11726 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2004 | 818 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 11366 | 0.010 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2004 | 857 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 1641 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2001 | 1005 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2005 | 1359 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 13693 | 0.010 |
Why?
|
| Age Factors | 1 | 2015 | 18373 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1997 | 85 | 0.010 |
Why?
|
| Multiple Myeloma | 2 | 2009 | 5181 | 0.010 |
Why?
|
| DNA | 1 | 2012 | 7294 | 0.010 |
Why?
|
| Oliguria | 1 | 1997 | 21 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7182 | 0.010 |
Why?
|
| Registries | 2 | 1991 | 8091 | 0.010 |
Why?
|
| Research Design | 1 | 2013 | 5984 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2004 | 984 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1997 | 190 | 0.010 |
Why?
|
| Renal Plasma Flow | 1 | 1996 | 30 | 0.010 |
Why?
|
| Mexican Americans | 1 | 1997 | 165 | 0.010 |
Why?
|
| Texas | 1 | 1997 | 391 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2001 | 10252 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 25628 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 35425 | 0.010 |
Why?
|
| Diabetes Mellitus | 2 | 2005 | 5749 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1997 | 2274 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 29786 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1996 | 2029 | 0.010 |
Why?
|
| HIV Infections | 1 | 2014 | 16715 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 19905 | 0.000 |
Why?
|
| Bipolar Disorder | 1 | 1984 | 5027 | 0.000 |
Why?
|
| Child | 1 | 2015 | 77709 | 0.000 |
Why?
|
| Chemistry | 1 | 1985 | 352 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1985 | 518 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 11718 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1989 | 3914 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1985 | 1154 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1985 | 1101 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2001 | 20824 | 0.000 |
Why?
|